Related references
Note: Only part of the references are listed.Applying modern Omic technologies to the Neuronal Ceroid Lipofuscinoses
Rachel A. Kline et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2020)
Homozygous missense TPP1 mutation associated with mild late infantile neuronal ceroid lipofuscinosis and the genotype-phenotype correlation
Zi-Rong Chen et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2019)
Mutation update: Review of TPP1 gene variants associated with neuronal ceroid lipofuscinosis CLN2 disease
Emily Gardner et al.
HUMAN MUTATION (2019)
Clinical challenges and future therapeutic approaches for neuronal ceroid lipofuscinosis
Sara E. Mole et al.
LANCET NEUROLOGY (2019)
Study of Intraventricular Cerliponase Alfa for CLN2 Disease
Angela Schulz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Disease characteristics and progression in patients with late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease: an observational cohort study
Miriam Nickel et al.
LANCET CHILD & ADOLESCENT HEALTH (2018)
Management Strategies for CLN2 Disease
Ruth E. Williams et al.
PEDIATRIC NEUROLOGY (2017)
Cerliponase Alfa: First Global Approval
Anthony Markham
DRUGS (2017)
Diagnosis of neuronal ceroid lipofuscinosis type 2 (CLN2 disease): Expert recommendations for early detection and laboratory diagnosis
Michael Fietz et al.
MOLECULAR GENETICS AND METABOLISM (2016)
PP03.8 – 2898: Late language acquisition and unexplained epilepsy are indicators of easily detectable CLN2 disease
M. Nickel et al.
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2015)
Protracted late infantile ceroid lipofuscinosis due to TPP1 mutations: Clinical, molecular and biochemical characterization in three sibs
Raffaella Di Giacopo et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2015)
TPP1 DEFICIENCY: RARE CAUSE OF ISOLATED CHILDHOOD-ONSET PROGRESSIVE ATAXIA
Marisela E. Dy et al.
NEUROLOGY (2015)
NCL diseases - clinical perspectives
Angela Schulz et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
THE NEURONAL CEROID-LIPOFUSCINOSES
Michael J. Bennett et al.
DEVELOPMENTAL DISABILITIES RESEARCH REVIEWS (2013)
Neuronal ceroid lipofuscinosis type CLN2: A new rationale for the construction of phenotypic subgroups based on a survey of 25 cases in South America
Romina Kohan et al.
GENE (2013)
Autosomal Recessive Spinocerebellar Ataxia 7 (SCAR7) is Caused by Variants in TPP1, The Gene Involved in Classic Late-Infantile Neuronal Ceroid Lipofuscinosis 2 Disease (CLN2 Disease)
Yu Sun et al.
HUMAN MUTATION (2013)
Atypical CLN2 with later onset and prolonged course:: a neuropathologic study showing different sensitivity of neuronal subpopulations to TPP1 deficiency
Milan Elleder et al.
ACTA NEUROPATHOLOGICA (2008)
CLN2/TPP1 deficiency: The novel mutation IVS7-10A > G causes intron retention and is associated with a mild disease phenotype
C. Bessa et al.
MOLECULAR GENETICS AND METABOLISM (2008)
Neurological deterioration in late infantile neuronal ceroid lipofuscinosis
S. Worgall et al.
NEUROLOGY (2007)
Late infantile neuronal ceroid lipofuscinosis:: Quantitative description of the clinical course in patients with CLN2 mutations
R Steinfeld et al.
AMERICAN JOURNAL OF MEDICAL GENETICS (2002)
Share Paper
